Apply for a PHA Research Grant
"PHA's research program funds some of the best science and the brightest people in the nation."
- John Newman, MD, Vanderbilt University Medical Center
PHA provides grants to promising researchers in the field of pulmonary hypertension. The program fosters new leaders in the field by supporting their interest in PH research and providing them with opportunities to work with mentors and learn new skills. Researchers supported by PHA are looking for new methods for early detection, new treatments to prevent the onset of PH and ultimately a cure for this terrible illness.
PHA currently offers five active, independently reviewed cutting-edge research programs:
PHA/NHLBI Mentored Clinical Scientist Award (K08)/Mentored Patient-Oriented Research Career Development Award (K23)
A partnership with the National Heart, Lung, and Blood Institute (NHLBI) that supports junior investigators. Applications for 2015 consideration will be due on July 12, 2015.
PHA/ATS Research Fellowship in Pulmonary Arterial Hypertension
A partnership grant program with the American Thoracic Society supporting faculty-level researchers in the field of pulmonary hypertension within 1 to 5 years of the completion of their training. In 2015, PHA and the Foundation of the American Thoracic Society will be offering at least one (1) Research Fellowship award of $80,000. Letters of intent will be accepted from April 1, 2015 through June 15, 2015.
PHA Proof of Concept Research Grants
This program offers support for new research projects that should result in the development of data enabling the investigator to apply for a larger, hypotheses-driven research project. In 2015, PHA will be offering at least one (1) Proof of Concept award of $40,000. Letters of intent will be accepted from April 1, 2015 through June 15, 2015.
Robyn Barst Pediatric PH Research and Mentoring Program
A unique grant opportunity designed to fund mentoring and research opportunities in pediatric PH. In 2015, PHA will be offering three (3) Barst Fund awards of $50,000. Letters of intent will be accepted from April 1, 2015 through June 15, 2015. Learn more about the development of the Barst Fund
A partnership with the National Heart, Lung and Blood Institute at the National Institutes of Health that supports a comprehensive, deep phenotyping across the current World Health Organization (WHO)-classified pulmonary hypertension clinical Groups 1 through 5). This active funding area is currently not accepting applications. Learn more about the PVDOMICS program.